Skip to content

Clinical trials

Observational Lung Diseases, Interstitial trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Observational Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20141
20151
20171
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University2
Maastricht University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Amsterdam UMC, location VUmc1
Radboud University Medical Center1
St. Antonius Hospital1
University of Massachusetts, Worcester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial9
Idiopathic Pulmonary Fibrosis4
Sarcoidosis3
Inflammation2
Pulmonary Fibrosis2
Breast Neoplasms1
Fibrosis1
Pneumonia1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.